272 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Horwitz
    Horwitz
  4. Bajorin
    Bajorin
  5. Bosl
    Bosl
  6. Sheinfeld
    Sheinfeld
  7. Palomba
    Palomba
  8. Perales
    Perales
  9. Salles
    Salles
  10. Mazumdar
    Mazumdar

Groups

  1. Department of Medicine (159)
  2. Solid Tumor Oncology Division (90)
  3. Hematologic Malignancies, Division of (77)
  4. Center for Hematologic Malignancies (73)
  5. Genitourinary Oncology Service (53)
  6. Survivorship Research (43)
  7. Surgery (41)
  8. Lymphoma (39)
  9. GSK Faculty (37)
  10. Epidemiology and Biostatistics (28)
  1. "lactate dehydrogenase"
Formats
  1. Journal Article (247)
  2. Review (9)
  3. Research Letter (8)
  4. Conference Paper (3)
  5. Editorial (3)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (159)
  2. Solid Tumor Oncology Division (90)
  3. Hematologic Malignancies, Division of (77)
  4. Center for Hematologic Malignancies (73)
  5. Genitourinary Oncology Service (53)
  6. Survivorship Research (43)

More Groups

People
  1. Robert Motzer (24)
  2. Howard Scher (16)
  3. Steven Horwitz (14)
  4. George Bosl (13)
  5. Dean Bajorin (12)
  6. Joel Sheinfeld (10)

More People

Years
  1. 2025 (16)
  2. 2024 (26)
  3. 2023 (16)
  4. 2022 (13)
  5. 2021 (7)
  6. 2020 (12)

More Years

Publications
  1. Journal of Clinical Oncology (23)
  2. Cancer (20)
  3. Haematologica (9)
  4. Blood (7)
  5. Leukemia and Lymphoma (7)
  6. Annals of Surgical Oncology (6)

More Publications

Publishers
  1. Wiley Blackwell (31)
  2. Elsevier Inc. (28)
  3. American Society of Clinical Oncology (24)
  4. Nature Publishing Group (19)
  5. Elsevier Science, Inc. (17)
  6. Springer (14)

More Publishers

Results (272)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of frailty subgroups of older adults (age ≥ 70) treated with teclistamab: An International Myeloma Foundation immunotherapy database real-world analysis: IMMUNOTHERAPY
    Correspondence

    Mian, H.; Martin, T. G.; Pond, G. R.; Asoori, S.; Popat, R.; Kastritis, E.; Martinez-Lopez, J.; Abdallah, N.; Chhabra, S.; Parrondo, R.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD–mutated AML
    Journal Article

    Levis, M. J.; Hamadani, M.; Logan, B. R.; Jones, R. J.; Singh, A. K.; Litzow, M. R.; Wingard, J. R.; Papadopoulos, E. B.; Perl, A. E.; Soiffer, R. J.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Predicting progression events in multiple myeloma from routine blood work
    Journal Article

    Ferle, M.; Grieb, N.; Kreuz, M.; Ader, J.; Goldschmidt, H.; Mai, E. K.; Bertsch, U.; Platzbecker, U.; Neumuth, T.; Reiche, K.; more...
    npj Digital Medicine (2025)

    Fulltext@MSK | Save
  • Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data
    Journal Article

    Yoo, S. K.; Fitzgerald, C. W.; Cho, B. A.; Fitzgerald, B. G.; Han, C.; Koh, E. S.; Pandey, A.; Sfreddo, H.; Crowley, F.; Korostin, M. R.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Management approaches for primary hepatic lymphoma: 10 year institutional experience with comprehensive literature review
    Journal Article

    Ma, J.; Daou, R.; Bou Eid, J.; Fregonese, B.; El-Khoury, J.; Wijetunga, N. A.; Imber, B. S.; Yahalom, J.; Hajj, C.
    Frontiers in Oncology (2025)

    Fulltext@MSK | Save
  • Double hit & double expressor lymphomas: A multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy
    Journal Article

    Karmali, R.; Shouse, G.; Torka, P.; Moyo, T. K.; Romancik, J.; Barta, S. K.; Bhansali, R.; Cohen, J. B.; Shah, N. N.; Zurko, J.; more...
    Blood Cancer Journal (2025)

    Fulltext@MSK | Save
  • Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: Analysis of key subgroups of the MAIA study
    Journal Article

    Moreau, P.; Facon, T.; Usmani, S. Z.; Bahlis, N.; Raje, N.; Plesner, T.; Orlowski, R. Z.; Basu, S.; Nahi, H.; Hulin, C.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Development of ALL-Hematotox: Predicting post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia
    Journal Article

    Nair, M. S.; Silbert, S. K.; Rejeski, K.; Wilson, K. A.; Lamble, A. J.; Valtis, Y.; Yates, B.; Morales Arana, A.; Shouval, R.; Curran, K.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: A real-world analysis from 21 US centers
    Journal Article

    Zelikson, V.; Gurumurthi, A.; Sawalha, Y.; Annunzio, K.; Saha, A.; Dong, N.; Qualls, D.; Amoozgar, B.; Kahl, B.; Baird, J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Goldman, A.; Tomas, A. A.; Fein, J. A.; Slingerland, J. B.; Parascondola, A.; Lin, R. J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save